(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States...
Stats | |
---|---|
Today's Volume | 3 681.00 |
Average Volume | 3 980.00 |
Market Cap | 27.76M |
EPS | $0 ( 2024-03-29 ) |
Next earnings date | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0200 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-08 | Mintz Steven | Sell | 0 | Common Stock, $0.0001 par value |
2024-01-08 | Mintz Steven | Sell | 63 756 | Option to Purchase Common Stock |
2023-08-09 | Renondin Jean-christophe | Sell | 25 821 | Option to Purchase Common Stock |
2023-04-25 | Juvenescence Ltd | Buy | 756 429 | Warrant to Purchase Common Stock |
2023-03-14 | Juvenescence Ltd | Sell | 16 447 500 | Common Stock |
INSIDER POWER |
---|
-62.48 |
Last 97 transactions |
Buy: 22 648 571 | Sell: 17 037 050 |
AgeX Therapeutics Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AgeX Therapeutics Inc Financials
Annual | 2023 |
Revenue: | $142 000 |
Gross Profit: | $-29 000.00 (-20.42 %) |
EPS: | $-13.72 |
Q4 | 2023 |
Revenue: | $56 000.00 |
Gross Profit: | $22 000.00 (39.29 %) |
EPS: | $-3.20 |
Q3 | 2023 |
Revenue: | $46 000.00 |
Gross Profit: | $13 000.00 (28.26 %) |
EPS: | $-5.01 |
Q2 | 2023 |
Revenue: | $9 000.00 |
Gross Profit: | $4 000.00 (44.44 %) |
EPS: | $-2.47 |
Financial Reports:
No articles found.
AgeX Therapeutics Inc
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators